Джозеф Меркола - Кето-навигатор

37. Popeski D, Ebbeling LR, Brown PB, et al. Blood pressure during pregnancy in Canadian Inuit: community differences related to diet. CMAJ . 1991 Sep 1; 145 (5): 445–454.

38. Williams MA, Zingheim RW, King IB, et al. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology. 1995 May; 6 (3): 232–237.

39. Там же.

40. Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol . 1995 Feb; 102 (2): 95–100.

41. Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev . 2003 Nov; 8 (4): 410–425.

42. Klerman GL, Weissman MM. Increasing rates of depression. JAMA .1989 Apr 21; 261 (15): 2229–2235.

43. Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry . 2001; 62 Suppl 16: 18–25.

44. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry . 2010 Jul 15; 68 (2): 140–147.

45. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv . 2001 Apr; 52 (4): 529–531.

46. Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biol Psychiatry . 1998 Mar 1; 43 (5): 313–314.

47. Там же.

48. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging . 2012 Jul; 33(7): 1482.e17–29.

49. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferongamma in T cells. Immunopharmacology. 1996 Aug; 34 (1): 27–37.

50. Serhan CN, Arita M, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004 Nov; 39 (11): 1125–1132.

51. Hibbeln JR. Fish consumption and major depression. Lancet. 1998 Apr 18; 351 (9110): 1213.

52. Hibbeln JR, Gow RV. The potential for military diets to reduce depression, suicide, and impulsive aggression: a review of current evidence for omega-3 and omega-6 fatty acids. Mil Med . 2014 Nov; 17911 Suppl): 117–128.

53. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv . 2001 Apr; 52 (4): 529–531.

54. Silvers KM, Scott KM. Fish consumption and self-reported physical and mental health status. Public Health Nutr . 2002 Jun; 5 (3): 427–431.

55. Adams PB, Lawson S, Sanigorski A, et al. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996 Mar; 31 Suppl: S157–161.

56. Tiemeier H, van Tuijl HR, Hofman A, et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr . 2003 Jul; 78 (1): 40–46.

57. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids . 2002 Nov; 67 (5): 311–318.

58. Hibbeln JR. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord . 2002 May; 69 (1–3): 15–29.

59. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging . 2012 Jul; 33 (7): 1482.e17–29.

60. Там же.

61. Там же.

62. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry . 2002 Mar; 159 (3): 477–479.

63. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol . 2003 Aug; 13 (4): 267–271.

64. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry . 2010 Jul 15; 68 (2): 140–147.

65. Grosso G, Pajak A, Marventano S, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One . 2014; 9 (5): e96905.

66. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry . 2002 Mar; 159 (3): 477–479.

67. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry . 2002 Oct; 59 (1): 913–919.

68. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry . 2006 Jan; 188: 46–50.

69. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry . 2006 Jun; 163 (6): 1098–1100.

70. Su KP, Huang SY, Chiu TH, et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry . 2008 Apr; 69 (4): 644–651.

71. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry . 2008 Mar; 42 (3): 192–198.

72. Jadoon A, Chiu CC, McDermott L, et al. Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression. J Affect Disord . 2012 Feb; 136 (3): 918–925.

73. Wolfe AR, Ogbonna EM, Lim S, et al. Dietary linoleic and oleic fatty acids in relation to severe depressed mood: 10 years follow-up of a national cohort. Prog Neuropsychopharmacol Biol Psychiatry . 2009 Aug 31; 33 (6): 972–977.

74. Lucas M, Mirzaei F, O’Reilly EJ, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr . 2011 Jun; 93 (6): 1337–1343.

75. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

76. Там же.

77. Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – a placebo-controlled double-blind study. Eur J Clin Nutr . 2004 Mar; 58 (3): 467–473.

78. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003 Oct; 38 (1): 1007–1021.

79. Vancassel S, Durand G, Barthelemy C, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids . 2001 Jul; 65 (1): 1–7.

80. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

81. Там же.

82. Amminger GP, Berger GE, Schafer MR, et al. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry . 2007 Feb 15; 61 (4): 551–553.